Answers are grounded in this paper and cite their sources.
Commentary highlights risks of rapid drug use in clinical settings, suggesting caution in evaluating medical research impacts.
INCREASED dissemination of information regarding medical research and rapid and effective marketing of new remedies has created considerable pressure for the immediate use of new drugs. Dangers of lack of critical evaluation of therapeutic procedures have been dramatically illustrated by the discovery of the relationship between use of atmospheres of high oxygen concentration in the treatment of prematures and development of retrolental fibroplasia. The evaluation of the effect of adrenocortical and adrenocorticotropic hormones in rheumatic fever poses a problem not subject to simple solution. Difficulties center around characteristics both of the disease and of the drugs. Since rheumatic fever has not been reproduced in any species other than man, testing of therapy must occur at the clinical level.
No takes yet. Share an insight, caveat, or question.
Albert Dorfman (1955) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: